QA: VACCINEX INC. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001205922_2020_VACCINEX_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001205922, VACCINEX INC.

  xvar xval
0 AssetsCurrent 4,010,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 594,000
3 remainder_Assets 0
4 LiabilitiesCurrent 3,208,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 3,670,000
7 CostOfGoodsAndServicesSold 199,000
8 SellingGeneralAndAdministrativeExpense 6,669,000
9 ResearchAndDevelopmentExpense 25,670,000
10 remainder_Expenses 0
11 remainder_Revenues 523,000
12 remainder_NetIncome 152,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,604,000
1 Liabilities 6,878,000
2 Expenses 32,538,000
3 Revenues 523,000
4 StockholdersEquity -2,274,000
5 NetIncome -31,863,000
6 ComprehensiveNetIncome -31,863,000
7 BaseVar 22,347,500
8 EconomicCapitalRatio -6.23

Edgar->Model Mapping

Feature Distribution

Change over Time